Stay updated on Sitravatinib Combo Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.

Latest updates to the Sitravatinib Combo Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include information about Enfortumab Vedotin-Ejfv and Ipilimumab, while removing details about Sitravatinib and its associated study. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference15%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.